Yoram has served as CFO of public and private primarily technology companies for over 25 years.  As the CFO of Fundtech where he served for over 11 years he was part of a team that successfully turned around the company from a $40M losing business into a profitable $200M company , concluding with a successful sale of Fundtech to the Private Equity firm , GTCR. Prior to Fundtech Yoram was the CFO of Viryanet in its pre-IPO days and was responsible for its successful IPO.    Yoram was also the CFO of Americash that was sold to American Express as well as various other companies including more recently, Brainstorm Cell Therapeutics, a NASDAQ listed biotechnology company developing stem cell therapies to treat neurodegenerative diseases .

Executive Team